Properties of three different molecular forms of the alpha 2 plasmin inhibitor.
D015119:Aminocaproic Acid / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D010450:Endopeptidases / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D006801:Humans; D005779:Immunodiffusion; D008970:Molecular Weight; D009194:Myeloma Proteins / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism; D000979:alpha-2-Antiplasmin
D009194:Myeloma Proteins; D000979:alpha-2-Antiplasmin; C033209:myeloma cell activator; D005337:Fibrin; D010958:Plasminogen; D010450:Endopeptidases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator; D015119:Aminocaproic Acid